GSK considers splitting up
GlaxoSmithKline is reportedly considering whether to split its business into a consumer health spin-off and standalone pharmaceutical and vaccines group.
Read More
Tag: consumer health
Pfizer re-organises into three business units
Pfizer has announced a re-organisation of its operations into three distinct businesses.
Read More
Merck sells consumer healthcare unit to P&G
Germany’s Merck is selling its consumer health unit to Procter & Gamble for around for 3.4 billion Euros.
Read More
GSK to buy-out Novartis’ stake in consumer health JV
GlaxoSmithKline is buying Novartis’ stake in the firms’ consumer healthcare unit, the announcement coming just days after the drug giant said it would not pursue acquisition of Pfizer’s consumer healthcare business.
Read More
Pfizer considers sale of consumer health division
Pfizer says it is considering the future of its massive consumer health division, with options including a full or partial separation of the business through a spin-off, sale or other transaction, or keeping hold of the unit.
Read More
Merck considers future of consumer health unit
Germany’s Merck is considering the future of its consumer health segment, including a potential full or partial sale of the business as well as new strategic partnerships.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
